Use of complementary and alternative medicine in Shanghai outpatients with chronic kidney disease: a cross-sectional survey

Author:

Xiao Yao1,Zhang Li2,Zhang Jing3,Zhou Liuliu4,Lu Yeyun4,Jiang Yufeng4,Zheng Xiaodong5

Affiliation:

1. The Second Rehabilitation Hospital of Shanghai

2. Shanghai Sixth People's Hospital

3. Huangpu Branch, Shanghai Ninth People's Hospital

4. Chongming Branch, Shanghai Tenth People's Hospital

5. Zhenru Street Community Health Center, Putuo District, Shanghai

Abstract

Abstract Background: Complementary and alternative medicine (CAM) measures are widely used by patients with chronic kidney disease (CKD), but their safety and efficacy have also been questioned. The purpose of this study was to determine the extent of CAM use by patients with CKD and to analyze the CAM-related information. Methods: This was a cross-sectional study performed in Shanghai. In brief, 491 patients with CKD were studied in three hospitals from June to August 2022. Patients were selected using convenience sampling. The questionnaire was comprised of standard demographic questions as well as questions related to the use of CAM measures. Results: Most CKD patients (80.58%) reported using CAM therapy, and the most common measures were medicinal herbs (87%) and acupuncture (31%). In general, CAM measures were used to treat co-morbidities (46.89%) and CKD (36.01%). Furthermore, 47.15% of patients reported using CAM therapy for 6 months, and 77.98% of patients did not disclose the use of CAM therapy to their physicians because they were not asked about it (69.77%). Approximately two-thirds of patients reported CAM to have benefits, and side effects were mentioned by 21.5% of patients. CAM therapy did not cause financial burdens for 70% of patients, and they would recommend CAM to relatives and friends. Conclusion: CAM is widely used by patients with CKD, and medicinal herbs are the most common measure. Patients initiated CAM therapy after receiving information from relatives and friends. Healthcare professionals should be aware of the use of CAM measures to control and prevent adverse effects when combined with conventional medicines and treatments.

Publisher

Research Square Platform LLC

Reference50 articles.

1. Kidney Disease–Improving Global Outcomes (KDIGO), 2012 Clinical practice guidelines for the evaluation and management of chronic kidney disease, Kidney Int. (2013) Suppl. 3 https://kdigo.org/wp-content/uploads/2017/02/ KDIGO_ 2012_CKD_GL.pdf

2. Chronic kidney disease: global dimension and perspectives;Jha V;Lancet,2013

3. Association of estimated glomerular filtration rate and proteinuria with all-cause mortality in community-based population in China: a result from Kailuan Study;Wu J;Sci Rep.,2018

4. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories;Foreman KJ;Lancet,2018

5. Prevalence of chronic kidney disease in China: a cross-sectional survey;Zhang L;Lancet,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3